KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Payables (2019 - 2025)

Historic Payables for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $28.7 million.

  • GoodRx Holdings' Payables rose 13182.15% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 13182.15%. This contributed to the annual value of $14.1 million for FY2024, which is 6101.86% down from last year.
  • As of Q3 2025, GoodRx Holdings' Payables stood at $28.7 million, which was up 13182.15% from $25.4 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Payables ranged from a high of $36.3 million in Q4 2023 and a low of $6.8 million during Q2 2023
  • For the 5-year period, GoodRx Holdings' Payables averaged around $19.0 million, with its median value being $16.9 million (2024).
  • Per our database at Business Quant, GoodRx Holdings' Payables soared by 20313.22% in 2023 and then crashed by 6234.31% in 2024.
  • GoodRx Holdings' Payables (Quarter) stood at $17.5 million in 2021, then rose by 1.14% to $17.7 million in 2022, then soared by 104.89% to $36.3 million in 2023, then crashed by 61.02% to $14.1 million in 2024, then surged by 103.19% to $28.7 million in 2025.
  • Its last three reported values are $28.7 million in Q3 2025, $25.4 million for Q2 2025, and $15.3 million during Q1 2025.